New National Public Opinion Poll Shows Majority of Americans Would Participate in Clinical Trials if Recommended by Their Doctor
Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research
ALEXANDRIA, Va.-June 12, 2013 – More than two-thirds (72%) of Americans say it’s likely they would participate in a clinical trial if recommended by their doctor, but only 22% say a doctor or other health care professional has ever talked to them about medical research, according to a new national public opinion poll commissioned by Research!America. A wide majority (80%) say they have heard of a clinical trial – more than half (53%) through the Internet and only 24% from a doctor or other health care provider.
Only 16% of those polled say they or someone in their family have ever participated in clinical trials. Respondents believe individuals don’t participate because of a lack of awareness (53%), a lack of trust (53%), concerns that it’s too risky (51%), adverse health outcomes (44%), little or no monetary compensation (35%), privacy concerns (27%), and worries that it takes too much time (27%).
The findings point to the important role of health care providers in talking to their patients about clinical trials. “It is critical for providers and health systems in the U.S. to recognize the importance of generating knowledge about which treatments are best through participation in clinical trials,” said Robert Califf, MD, vice chancellor of clinical and translational research at Duke University Medical Center and board chair of the Clinical Research Forum, a co-sponsor of the poll. “Advances in common diseases like Alzheimer’s and diabetes, as well as rare diseases, depend on physicians and other members of the health care team offering their patients a chance to participate in clinical trials.” Continue reading →
October 10, 2012
We congratulate Dr. Robert Lefkowitz and Dr. Brian Kobilka on the announcement of the Nobel Prize in chemistry for their groundbreaking work on protein receptors, paving the way for the development of new drugs to halt the rampage of disease. Patients benefit from unwavering commitment to putting research to work. Lefkowitz, an investigator at the Howard Hughes Medical Institute and professor at Duke University Medical Center, and Kobilka of Stanford University School of Medicine, have demonstrated that scientific discovery is the result of painstaking work supported by both the public and private sector. Throughout their careers, both have received government funding for various studies that have culminated in this remarkable achievement. This is an apt illustration of the value of sustained public investment in science. Dr. Shinya Yamanaka of Gladstone Institutes, one of the winners of the Nobel Prize for medicine and physiology, was also supported by the National Institutes of Health. This week’s winners are among the many Nobel laureates whose incredible work was made possible by support from the American taxpayer. We must continue to assure our nation’s leadership in scientific discovery with a strong investment in research and innovation.